Nafamostat mesylate augments survival in rats afflicted by exertional heat stroke

Nafamostat mesylate augments survival in rats afflicted by exertional heat stroke

ObjectiveTo evaluate the impact of Nafamostat mesylate (NM) in improving survival outcomes among rats subjected to exertional heat stroke.MethodsThis study involved a cohort of 45 specific pathogen-free (SPF) male Sprague Dawley (SD) rats. After successfully inducing exertional heat stroke, the rats...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qingwei Lin, Zhuqing Luo, Longping He, Lincui Zhong, Qingbo Zeng, Ye Zhou, Qi Chen, Xingping Deng, Xiaomin Song, Qing Song, Jingchun Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Pharmacology
Subjects:	nafamostat mesylate rats heatstroke proteomics thrombosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1559181/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nafamostat mesylate versus regional citrate anticoagulation for chronic hemodialysis in patients at high risk of bleeding: a single-center, retrospective study
by: Jiangtao Li, et al.
Published: (2025-12-01)

Nafamostat Mesylate Regulates Glycosylation to Alleviate Aristolochic Acid Induced Kidney Injury
by: Pei Xie, et al.
Published: (2025-03-01)

Developing a molecular diagnostic model for heatstroke-induced coagulopathy: a proteomics and metabolomics approach
by: Qingbo Zeng, et al.
Published: (2025-06-01)

Preventive administration of shengmaiyin: a novel approach to counteract heatstroke-induced coagulopathy in rats
by: Longping He, et al.
Published: (2025-03-01)

Pharmacokinetic and pharmacodynamic analyses of nafamostat in ECMO patients: comparing central vein and ECMO machine samples
by: Dong Hwan Lee, et al.
Published: (2025-05-01)

Efficacy and safety of nafamostat mesilate for sepsis (EASNMS): study protocol for a multicenter randomized controlled trial
by: Hongyu Yang, et al.
Published: (2025-07-01)

Non-invasive urinary proteomic biomarkers for prognostic assessment in sepsis
by: Qingbo Zeng, et al.
Published: (2025-07-01)

Eribulin mesylate exerts antitumor effects via CD103
by: Kazumasa Oya, et al.
Published: (2023-12-01)

Effect of nafamostat in continuous renal replacement therapy for patients at risk of bleeding
by: TANG Xiaofang*, ZHANG Xu, JIANG Chunming, ZHANG Xijun, TANG Peng, LI Kangfeng
Published: (2025-04-01)

Determination of imatinib mesylate and erlotinib hydrochloride in mice plasma using ultrahigh performance liquid chromatography method
by: Gülen Melike Demir, et al.
Published: (2018-08-01)

Advances in the comprehensive mechanisms, diagnosis, and treatment of heatstroke-induced coagulopathy
by: Chuhan Xiang, et al.
Published: (2025-07-01)

Nail lichen planus associated with imatinib mesylate
by: Eden Axler, BS, et al.
Published: (2025-04-01)

A rare case of eye complications of gastric stromal tumor treatment using imatinib mesylate
by: E. B. Myakoshina, et al.
Published: (2020-09-01)

Human Transmembrane Serine Protease 2 (TMPRSS2) on Human Seminal Fluid Extracellular Vesicles Is Proteolytically Active
by: Emile Verhulst, et al.
Published: (2025-03-01)

Cardiovascular magnetic resonance feature tracking derived strain analysis can predict return to training following exertional heatstroke
by: Jun Zhang, et al.
Published: (2024-01-01)

Efficacy of Deferoxamine Mesylate in Serum and Serum-Free Media: Adult Ventral Root Schwann Cell Survival Following Hydrogen Peroxide-Induced Cell Death
by: Yee Hang Ethan Ma, et al.
Published: (2025-03-01)

Human Umbilical Cord Blood Cells Protect Against Hypothalamic Apoptosis and Systemic Inflammation Response During Heatstroke in Rats
by: Won-Shiung Liu, et al.
Published: (2009-10-01)

Comparison of Socal Score and Hasford Score Against the Response of Imatinib Mesylate Therapy in Patients with Chronic Granulocytic Leukemia in dr. Saiful Anwar Hospital Malang
by: Somarnam, et al.
Published: (2019-12-01)

Persistent thrombocytopaenia as an independent risk factor for 28-day mortality and multiorgan failure in exertional heatstroke: a retrospective study of 217 patients
by: Li Zhong, et al.
Published: (2025-12-01)

HMGB1 released from pyroptotic vascular endothelial cells promotes immune disorders in exertional heatstroke
by: Chaoping Yu, et al.
Published: (2024-12-01)

Adrenal steroid hormone responses to exercise under thermal stress: Potential role for nonclassic congenital adrenal hyperplasia in heat illness susceptibility
by: Michael J. Stacey, et al.
Published: (2025-03-01)

Diagnosis and Management of Heatstroke
by: I Gede Yasa Asmara
Published: (2020-04-01)

Diagnosis and Management of Heatstroke
by: I Gede Yasa Asmara
Published: (2020-04-01)

Incidence of BCR-ABL transcript variants in patients with chronic myeloid leukemia: Their correlation with presenting features, risk scores and response to treatment with imatinib mesylate
by: Pratik Deb, et al.
Published: (2014-01-01)

Anaphylactic Reactions Caused by Nafamostat Mesylate during Hemodialysis before Surgery for Carpal Tunnel Syndrome
by: Yuta Nakamura, et al.
Published: (2021-01-01)

Development and validation of the predictive scoring system for 90-day mortality in critical ill patients with exertional heatstroke
by: Jiali Cun, et al.
Published: (2025-12-01)

Serum myoglobin as predictor of acute kidney injury and 90-day mortality in patients with rhabdomyolysis after exertional heatstroke: an over 10-year intensive care survey
by: Ming Wu, et al.
Published: (2022-12-01)

Postoperative Cure for Metastatic Gastrointestinal Stromal Tumor
by: Eun Hyea Park, et al.
Published: (2018-12-01)

Dermatofibrosarcoma: report of a case with complete response to imatinib and conservative surgery during the COVID-19 pandemic
by: Rafael Martins Steffen, et al.
Published: (2022-10-01)

L-carnitine ameliorates myocardial injury by alleviating endoplasmic reticulum stress via inhibition of PERK pathway in exertional heatstroke rats
by: Bo-Yi Zhang, et al.
Published: (2024-11-01)

Spectrofluorimetric determination of gemifloxacin mesylate and linezolid in pharmaceutical formulations: Application of quinone-based fluorophores and enhanced native fluorescence
by: Moussa Bahia Abbas, et al.
Published: (2014-03-01)

Environmental high temperature induced cartilage damage through triggering programmed necrosis mediated by producing left-handed DNA
by: Sun Yingfei, et al.
Published: (2025-02-01)

Long‐term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14‐year, single‐center experience
by: Jwa Hoon Kim, et al.
Published: (2019-03-01)

Risk factors and predictive models for sequelae of heat stroke primarily involving cerebellar dysfunction
by: Xiao-Xiao Ni, et al.
Published: (2024-12-01)

Heatstroke characteristics and meteorological conditions in Hefei, China: thresholds and driving factors
by: Xueliang Deng, et al.
Published: (2025-01-01)

Suppressing TLR4 alleviates cerebral injury in heatstroke rats through the modulation of microglial polarization
by: Xiaomin Wu, et al.
Published: (2025-12-01)

Comparison of regional citrate anticoagulation and nafamostat mesylate anticoagulation during plasma exchange for children at high bleeding risk: a retrospective study
by: Dan Peng, et al.
Published: (2025-04-01)

Controllable nickel ions release from deferoxamine mesylate-triggered nickel-iron layered double hydroxide for eliciting apoptotic cell death in prostate cancer
by: Zhengbin Wang, et al.
Published: (2025-05-01)

Heatstroke-Induced Inflammatory Response and Therapeutic Biomarkers
by: Piyush Baindara, et al.
Published: (2025-01-01)

Lack of Association between C1236T, G2677T/A and C3435T Variants of the ABCB1 Gene and Imatinib Response in Iranian Chronic Myeloid Leukemia Patients
by: Maedeh Khosravi, et al.
Published: (2021-05-01)